A method is provided for treating a dermatological condition in a patient. The method includes (a) measuring the intracellular water content of the patient to provide an initial intracellular water content measurement; (b) administering to the patient at least one active agent; (c) re-measuring the intracellular water content of the patient to provide a post-treatment intracellular water content measurement; and (d) repeating steps (b) and (c) until the post-treatment intracellular water content measurement is greater than the initial intracellular water content measurement. A method is also provided for treating other health-related conditions in a patient.

 
Web www.patentalert.com

< Metabolites of (+)-(2S,3S)-3(2-methoxy-5- trifluoromethoxybenzylamino)-2-p- henyl-piperidine

< Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase

> Prostaglandin compounds for the treatment of obesity

> Regulation of human serine-threonine protein kinase
~ 00222